Glaxosmithkline Share News (GSK)

WHO urges drug companies, regulators to speed Ebola work

* WHO hosts two-day talks on experimental Ebola therapies * Says eight drugs and two vaccines have shown potential * Calls for speeding work on developing safe, efficient treatments * A few hundred doses of ZMapp may be available by year-end * Newlink gets FDA nod for clin

BUZZ-U.S. Stocks on the Move-Ciena, Matrix, Methode, Mitek

(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for more market insights, including options activity, ; for the Day Ahead newsletter, http://link.reuters.com/mex49s; for the Morning News Call newsletter, http://link.reuters.com/nex49s) U.S.

BUZZ-U.S. Stocks on the Move-Kamada, Mitek, Stereotaxis, Shoe Carnival

(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for more market insights, including options activity, ; for the Day Ahead newsletter, http://link.reuters.com/mex49s; for the Morning News Call newsletter, http://link.reuters.com/nex49s) U.S.

BUZZ-U.S. Stocks on the Move-Ciena, Mitek, GoPro, Memorial Production

(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for more market insights, including options activity, ; for the Day Ahead newsletter, http://link.reuters.com/mex49s; for the Morning News Call newsletter, http://link.reuters.com/nex49s) U.S.

Nigeria monitoring 400 contacts of doctor who died of Ebola

* Sense of "hopelessness" in Nigeria, health official says * Nigeria quarantining high-risk contacts of late doctor * Doctor hid his exposure and infection, putting others at risk * WHO opens two-day talks on experimental drugs, vaccines By Stephanie Nebehay GENEVA,

J&J Ebola vaccine to start clinical trials in early 2015

* J&J working with Bavarian Nordic and U.S scientists * Vaccine programme accelerated in light of current crisis * Move follows plan to fast-track GSK and Canadian vaccines By Ben Hirschler Sept 4 (Reuters) - Scientists will fast-track tests on another Ebola vaccine, this

Guinea detects Ebola in new region as U.S. warns outbreak out of control

* Guinea finds new infections in southeast region * President says healthcare staff "dropped the ball" * U.S. doctor says outbreak is not under control anywhere * U.S. official rebuts call for disaster response teams By Saliou Samb and Daniel Flynn CONAKRY/DAKAR, Sep

Glaxo HIV Joint Venture Gets EU Marketing Authorisation For Triumeq

UPDATE 1-British Ebola patient discharged from hospital after ZMapp treatment

(Adds quotes from patient) LONDON, Sept 3 (Reuters) - A British man who contracted Ebola in West Africa has been discharged after successful treatment with the experimental ZMapp drug, the Royal Free Hospital in London said on Wednesday. William Pooley, 29, was treated in a special is

GSK's chairman urged to resign earlier over China bribery scandal

UK pharmaceutical group GlaxoSmithKline (GSK) is facing rebellion from its shareholders as they call for an early departure from chairman Christopher Gent, reports said. Gent has been GSK's chairman for nine years, and announced earlier this year he would resign in 2015. However, shareholders wor

FTSE 100 movers: ITV a strong riser on bid speculation

Shares in ITV were rising strongly on Monday on renewed speculation that Liberty Global could be preparing to launch a full-scale bid for the UK broadcaster. According to The Telegraph over the weekend, Liberty, which already owns a 6.4% stake in ITV through its investment in July, is "forming allia

India's Cipla launches copy of GSK's top asthma drug in Germany, Sweden

MUMBAI, Sept 1 (Reuters) - India's Cipla Ltd has launched an anti-asthma inhaler in Germany and Sweden that is a generic version of GlaxoSmithKline Plc's Advair, a move that will further dent sales of the British firm's top-selling product. Cipla's drug will be marketed under the name Serro

UK MIDDAY BRIEFING: Perform Group Surges On Access Industries Bid

UK WINNERS & LOSERS: Perform Group Tops FTSE 250, Up Over 25%

TOP NEWS: Vodafone Signs With Dixons Carphone And Ends Phones 4U Deal